HHS Medicare Rx Price Negotiations Would Fail For Lack Of Force, CMS Says
This article was originally published in The Pink Sheet Daily
Executive Summary
The current Administration, as well as those in the future, would not be willing or able to enforce drug prices significantly below competitive market rates, CMS Chief Actuary Foster says in memo. Giving HHS price negotiating authority would lead to restrictions on drug choice, Administrator McClellan asserts.